Gastric Adenocarcinoma Completed Phase 2 / 3 Trials for Ramucirumab (DB05578)

Back to Gastric Adenocarcinoma

Also known as: Adenocarcinoma gastric / Adenocarcinoma, Gastric / Gastric Adenocarcinomas / Adenocarcinoma of the Stomach / Stomach Adenocarcinoma / Gastric Cancer, Adenocarcinoma / Adenocarcinoma of stomach (disorder)

Indication	Status	Phase
DBCOND0030814 (Gastric Adenocarcinoma)	Completed	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04499924	Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer	Treatment	Paclitaxel (DB01229) Ramucirumab (DB05578) Trastuzumab (DB00072) Tucatinib (DB11652)